This trial is testing a patient navigator intervention to help people with diabetes who are at high risk of diabetic blindness. They want to see if it's feasible and acceptable before doing a bigger clinical trial.
- Diabetic Retinopathy
3 Primary · 0 Secondary · Reporting Duration: 18 months
Awards & Highlights
1 Treatment Group
1 of 1
60 Total Participants · 1 Treatment Group
Primary Treatment: Patient Navigation · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|Yale School of Medicine||100.0%|
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
- "I want to cure or slow my retinopathy."
How many prior treatments have patients received?
How responsive is this trial?
Average response time
- < 2 Days
Most responsive sites:
- Yale School of Medicine: < 48 hours
Typically responds via
- Nwanyanwu, Kristen M.J.H., Marcella Nunez-Smith, Thomas W. Gardner, and Mayur M. Desai. 2021. “Awareness of Diabetic Retinopathy: Insight from the National Health and Nutrition Examination Survey”. American Journal of Preventive Medicine. Elsevier BV. doi:10.1016/j.amepre.2021.05.018.
- 2022. "Patient Navigator Intervention for Diabetic Retinopathy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05188703.
Frequently Asked Questions
How many participants are being enrolled in the clinical trial?
"Affirmative. Data hosted on clinicaltrials.gov attests that this medical experiment, initially published on July 25th 2022 is recruiting participants as of now. Approximately 60 individuals are set to be enrolled in the trial at its lone site." - Anonymous Online Contributor
Has this research been opened up to new participants yet?
"That is correct. According to the information readily available on clinicaltrials.gov, this research project posted in late July 2022 and was recently updated at the beginning of September 2022 seeks 60 participants from a single medical centre." - Anonymous Online Contributor